Opportunistic Infections Citation List:
September 3 - September 16, 2010
OPPORTUNISTIC PROTOZOA COMPOUNDS (including pneumocystis, cryptosporidium, toxoplasma, microsporidia [encephalitozoon, enterocytozoon, vittaforma])
1. Toxoplasma gondii: Inhibitory Activity and Encystation Effect of Securinine and Pyrrolidine Derivatives on Toxoplasma Growth. Holmes, M., A.K. Crater, B. Dhudshia, A.N. Thadani, and S. Ananvoranich. Experimental Parasitology. 2010. [Epub ahead of print]; PMID[20833168].
[Pubmed]. OI_0903-091610.
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
2. Fungicidal activity of thymol and carvacrol by disrupting ergosterol biosynthesis and membrane integrity against Candida. Ahmad, A., A. Khan, F. Akhtar, S. Yousuf, I. Xess, L.A. Khan, and N. Manzoor. European Journal of Clinical Microbiology & Infectious Diseases.2010. [Epub ahead of print]; PMID[20835742].
[Pubmed]. OI_0903-091610.
3. Screening for antifungal peptides and their modes of action in Aspergillus nidulans. Mania, D., K. Hilpert, S. Ruden, R. Fischer, and N. Takeshita. Applied and Environmental Microbiology. 2010.[Epub ahead of print]; PMID[20833782].
[Pubmed]. OI_0903-091610.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
4. 3-Phenyl-1H-Indole-5-Sulfonamides: Structure-Based Drug Design of a Promising Class of Carbonic Anhydrase Inhibitors. Guzel, O., A. Innocenti, D. Vullo, A. Scozzafava, and C.T. Supuran. Current Pharmaceutical Design. 2010. [Epub ahead of print]; PMID[20819062].
[Pubmed]. OI_0903-091610.
5. Modular Approach to Triazole-Linked 1,6-alpha-d-Oligomannosides to the Discovery of Inhibitors of Mycobacterium tuberculosis Cell Wall Synthetase. Lo Conte, M., A. Marra, A. Chambery, S.S. Gurcha, G.S. Besra, and A. Dondoni. Journal of Organic Chemistry. [Epub ahead of print]; PMID[20822121].
[Pubmed]. OI_0903-091610.
6. Identification of novel antitubercular compounds through hybrid virtual screening approach. Muddassar, M., J.W. Jang, H.S. Gon, Y.S. Cho, E.E. Kim, K.C. Keum, T. Oh, S.N. Cho, and A.N. Pae. Bioorganic & Medicinal Chemistry. 18(18): p. 6914-21; PMID[20727773].
[Pubmed]. OI_0903-091610.
7. The hydroxy-naphthoquinone lapachol arrests mycobacterial growth and immunomodulates host macrophages. Oliveira, R.A., E. Azevedo-Ximenes, R. Luzzati, and R.C. Garcia. International Immunopharmacology. [Epub ahead of print]; PMID[20837170].
[Pubmed]. OI_0903-091610.
Citations from the ISI Web of Knowledge Listings for O.I.
8. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors. Borrelli, S., W.F. Zandberg, S. Mohan, M. Ko, F. Martinez-Gutierrez, S.K. Partha, D.A.R. Sanders, Y. Av-Gay, and B.M. Pinto. International Journal of Antimicrobial Agents. 36(4): p. 364-368; ISI[000281140600014].
[WOS]. OI_0903-091610.
9. Efficacy of S-adenosylhomocysteine hydrolase inhibitors, D-eritadenine and (S)-DHPA, against the growth of Cryptosporidium parvum in vitro. Ctrnacta, V., J.M. Fritzler, M. Surinova, I. Hrdy, G.A. Zhu, and F. Stejskal. Experimental Parasitology. 126(2): p. 113-116; ISI[000280885500001].
[WOS]. OI_0903-091610.
10. 1,3-Dipolar cycloaddition of nitrile oxides to (R)-1-(1-phenylethyl)-3,5-bis[(E)-arylmethylidene]tetrahydro-4(1H)-pyrid inones: synthesis and antimycobacterial evaluation of novel enantiomerically pure di- and trispiroheterocycles. Kumar, R.S., S.M. Rajesh, S. Perumal, P. Yogeeswari, and D. Sriram. Tetrahedron-Asymmetry. 21(11-12): p. 1315-1327; ISI[000281095300001].
[WOS]. OI_0903-091610.
11. Identification of Thiazolidinones Spiro-Fused to Indolin-2-ones as Potent and Selective Inhibitors of the Mycobacterium tuberculosis Protein Tyrosine Phosphatase B. Vintonyak, V.V., K. Warburg, H. Kruse, S. Grimme, K. Hubel, D. Rauh, and H. Waldmann. Angewandte Chemie-International Edition. 49(34): p. 5902-5905; ISI[000281105600013].
[WOS]. OI_0903-091610.